FinancialGovernment SolutionsLegalReuters News AgencyRisk Management SolutionsTax & AccountingBlog: Answers OnInnovation @ Thomson Reuters
Directory of sites
Login
Contact
Support
Top News
Detained in Myanmar
North Korea
Reuters Investigates
Tech
The Wider Image
The Road to Brexit
Syria
Sports
Commentary
Pictures
Healthcare
February 7, 2018 / 7:49 AM / 3 months ago

BRIEF-Sprint Bioscience Q4 Operating Result Swings To Loss Of SEK 7.2‍​ Million

Reuters Staff

1 Min Read

Feb 7 (Reuters) - SPRINT BIOSCIENCE AB:

* Q4 REVENUE SEK ‍​5.4 MILLION VERSUS SEK 13.0 MILLION YEAR AGO

* Q4 OPERATING LOSS SEK 7.2‍​ MILLION VERSUS PROFIT SEK 2.7 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

© 2018 Reuters. All Rights Reserved.